Evidence map›Paper›PMID 33832526›Full record

ArticleOrphanet journal of rare diseases2021

eHealth for patients with rare diseases: the eHealth Working Group of the European Reference Network on Rare Multisystemic Vascular Diseases (VASCERN).

Alessia Paglialonga, Raffaella Gaetano, Leema Robert, Marine Hurard, Luisa Maria Botella, Natasha Barr, Guillaume Jondeau, Alessandro Pini

Open access · goldAbstract read
In one paragraph

Article in Orphanet journal of rare diseases, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Review
  3. Rare disease education in Europe and beyond: time to act.Orphanet journal of rare diseases · 2022
    Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 6 institutions in 4 countries.

Alessia PaglialongaInstitute of Electronics, Information Engineering and Telecommunications (IEIIT), Italian National Research Council (CNR), Milan, Italy.
Raffaella GaetanoItalian National Research Council (CNR), Institute of Biomedical Research and Innovation (IRIB), Palermo, Italy.
Leema RobertDepartment of Clinical Genetics, VASCERN HTAD European Reference Centre, Guys and St Thomas NHS Foundation Trust, London, UK.
Marine HurardVASCERN Coordination Project-Team, Assistance Publique-Hôpitaux de Paris Hôpital Bichat-Claude Bernard, VASCERN HTAD European Reference Centre, Paris, France.
Luisa Maria BotellaAsociación HHT España, Almansa, Spain.
Natasha BarrVASCERN Coordination Project-Team, Assistance Publique-Hôpitaux de Paris Hôpital Bichat-Claude Bernard, VASCERN HTAD European Reference Centre, Paris, France.
Guillaume JondeauVASCERN Coordinator, Cardiology Department, Reference Center for Marfan Syndrome and Related Diseases, INSERM U1148 LVTS, Assistance Publique-Hôpitaux de Paris, Université de Paris, Hôpital Bichat-Claude Bernard, VASCERN HTAD European Reference Centre, Paris, France.
Alessandro PiniCardiovascular-Genetic Center, IRCCS Policlinico San Donato, Via Morandi 30, 20097, San Donato Milanese, MI, Italy. alessandro.pini@grupposandonato.it.ORCID 0000-0002-8325-6057
Université Claude Bernard Lyon 1 · FREuropean Patent Organisation · DEGuy's and St Thomas' NHS Foundation Trust · GBInstitute for Biomedical Research and Innovation · ITInstitute of Electronics, Computer and Telecommunication Engineering · ITInstitut Pasteur · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe European Reference Network on Rare Multisystemic Vascular Diseases (VASCERN) was launched in 2017 and involves, to date, 35 highly specialised multidisciplinary expert centres (from the 30 full Healthcare Provider members) coming from 11 countries and more than 70 patient organizations from 16 countries. The eHealth Working Group (WG) of VASCERN was set up to develop practical, patient-centred solutions and strategies for effective use of eHealth tools to answer the needs of patients with multisystemic vascular rare diseases. THE EHEALTH WG: Following the identified patients' needs and following the guiding principles of collaboration and patient-centredness, the eHealth WG was created with the following aims: to develop a mobile app to help patients find expert centres and patient organizations, and to develop resources (Pills of Knowledge, PoK) for training and education via digital platforms (eLearning). The mobile app includes, to date, functionalities that allow users to find expert centres and patient organizations across Europe in the area of rare multisystemic vascular diseases. Discussed app developments include personalized digital patient passports, educational material, emergency management guidelines and remote consultations. Regarding training and education, a variety of PoK have been developed. The PoK cover several topics, target several user groups, and are delivered in various formats so that they are easy-to-use, easy-to-understand, informative, and viable for delivery and sharing through digital platforms (eLearning) including, e.g., the VASCERN YouTube™ channel.

conclusionOverall, the work carried out by the eHealth WG of VASCERN can be seen as a pilot experience that may serve as a basis to for collaborative development of patient-centred eHealth tools that answer the needs of patients with various rare diseases, not limited to rare multisystemic vascular diseases. By expanding the multidisciplinary approach here described, clinical and research networks can take advantage of eHealth services and use them as strategic assets in achieving the ultimate goal of ensuring equity of access to prevention programs, timely and accurate diagnosis and specialized care for patients with rare diseases throughout Europe.

Indexed as

Mobile ApplicationsTelemedicineVascular DiseasesEuropeHumansRare DiseaseseHealthEuropean commission 3rd health programmeEuropean reference networkKnowledge exchangemHealthOrphan diseasesRare diseasesTelemedicineVascular diseases

Identifiers

PMID33832526
PMCPMC8034087
OpenAlexW3151406406

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.